ABT 719

Known as: ABT-719, ABT719 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2016
01219952016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Acute kidney injury (AKI) is a significant source of morbidity and mortality in pediatric patients, affecting more than one… (More)
  • figure 1
Is this relevant?
Review
2017
Review
2017
INTRODUCTION Despite significant need and historical trials, there are no effective drugs in use for the prevention or treatment… (More)
  • figure 1
  • figure 2
Is this relevant?
2016
2016
BACKGROUND Patients undergoing cardiac surgeries with cardiopulmonary bypass (on-pump) have a high risk for acute kidney injury… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
1999
1999
The antibacterial 4H-4-oxoquinolizines were introduced recently to overcome bacterial resistance to fluoroquinolones. They… (More)
Is this relevant?
1996
1996
ABT-719 is a 2-pyridone antimicrobial which inhibits DNA gyrase activity. It has considerable subcutaneous (sc) and oral efficacy… (More)
Is this relevant?
1996
1996
Two novel series of 2-pyridones were synthesized by transposition of the nitrogen of 4-quinolones to the bridgehead position… (More)
Is this relevant?
1995
1995
ABT-719 (A-86719.1) is the first compound of a new class of novel DNA gyrase inhibitors, the 2-pyridones, with potent… (More)
Is this relevant?
1995
1995
The 2-pyridones are a new class of broad-spectrum orally bioavailable antibacterial agents. These compounds are potent bacterial… (More)
Is this relevant?